Evidence map›Paper›PMID 29688801›Full record

ArticleMicrobial drug resistance (Larchmont, N.Y.)2018

Genomic Characterization of Nonclonal mcr-1-Positive Multidrug-Resistant Klebsiella pneumoniae from Clinical Samples in Thailand.

Apichai Srijan, Katie R Margulieux, Sirigade Ruekit, Erik Snesrud, Rosslyn Maybank, Oralak Serichantalergs, Rosarin Kormanee, Prawet Sukhchat, Jossin Sriyabhaya, Mary Hinkle and 3 more

Open access · greenAbstract read
In one paragraph

Article in Microbial drug resistance (Larchmont, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. The Co-Existence ofAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Characterization of aFrontiers in microbiology · 2021
    Article
  12. Review
  13. Plasmid MediatedFrontiers in microbiology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Apichai Srijan1 Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences , Bangkok, Thailand .
Katie R Margulieux1 Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences , Bangkok, Thailand .
Sirigade Ruekit1 Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences , Bangkok, Thailand .
Erik Snesrud2 The Multidrug Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research , Silver Spring, Maryland.
Rosslyn Maybank2 The Multidrug Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research , Silver Spring, Maryland.
Oralak Serichantalergs1 Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences , Bangkok, Thailand .
Rosarin Kormanee3 Queen Sirikit Naval Hospital , Chonburi, Thailand .
Prawet Sukhchat3 Queen Sirikit Naval Hospital , Chonburi, Thailand .
Jossin Sriyabhaya3 Queen Sirikit Naval Hospital , Chonburi, Thailand .
Mary Hinkle2 The Multidrug Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research , Silver Spring, Maryland.
John M Crawford1 Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences , Bangkok, Thailand .
Patrick McGann2 The Multidrug Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research , Silver Spring, Maryland.
Brett E Swierczewski1 Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences , Bangkok, Thailand .
Armed Forces Research Institute of Medical Science · THWalter Reed Army Institute of Research · USChonburi Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant Klebsiella pneumoniae strains are one of the most prevalent causes of nosocomial infections and pose an increasingly dangerous public health threat. The lack of remaining treatment options has resulted in the utilization of older drug classes, including colistin. As a drug of last resort, the discovery of plasmid-mediated colistin resistance by mcr-1 denotes the potential development of pandrug-resistant bacterial pathogens. To address the emergence of the mcr-1 gene, 118 gram-negative Enterobacteriaceae isolated from clinical samples collected at Queen Sirikit Naval Hospital in Chonburi, Thailand were screened for colistin resistance using automated antimicrobial susceptibility testing and conventional PCR screening. Two K. pneumoniae strains, QS17-0029 and QS17-0161, were positive for mcr-1, and both isolates were sequenced to closure using short- and long-read whole-genome sequencing. QS17-0029 carried 16 antibiotic resistance genes in addition to mcr-1, including 2 carbapenemases, bla

Indexed as

Aged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesColistinDrug Resistance, Multiple, BacterialEnterobacteriaceaeEscherichia coli ProteinsGenomicsHumansKlebsiella pneumoniaeMalePlasmidsThailandAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseColistinEscherichia coli ProteinsMCR-1 protein, E coliKlebsiella pneumoniaemcr-1MDROThailand

Identifiers

PMID29688801
PMCPMC5946733
OpenAlexW2801139450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.